-
公开(公告)号:NO20013958A
公开(公告)日:2001-10-15
申请号:NO20013958
申请日:2001-08-15
Applicant: SOLVAY PHARM GMBH
Inventor: WILKINS MARTIN R , THORMAEHLEN DIRK , WALDECK HARALD
IPC: C07D223/16 , A61K31/55 , A61P9/00 , A61P9/12 , A61D9/12
CPC classification number: A61K31/55
-
公开(公告)号:DE19932555A1
公开(公告)日:2001-01-18
申请号:DE19932555
申请日:1999-07-13
Applicant: SOLVAY PHARM GMBH
Inventor: ROZA ZSUZSANNA , PAPP JULIUS GY , THORMAEHLEN DIRK , WALDECK HARALD
IPC: C07D223/16 , A61K31/55 , A61K31/704 , A61K45/00 , A61K45/06 , A61P9/00 , A61P21/00 , A61P35/00 , A61P37/04 , A61P39/02 , A61P39/06
Abstract: The invention relates to the utilization of benzazepine-N-acetic acid derivatives which contain an oxogroup in addition to the nitrogen atom in the alpha position and which are substituted in the third position by a 1-(carboxyalkyl)-cyclopentyl-carbonyl-amino radical and to their salts and biolabile esters for the prophylaxis and/or treatment of heart damages caused by cardiotoxic doses of medicaments or chemicals in large mammals and particularly human beings. The invention particularly relates to the prophylaxis and/or treatment of heart damages, especially myocardial damages, which may occur during cytostatic chemotherapy. The invention further relates to the utilization of the above-mentioned benzazepine-N-acetic acid derivatives for adjuvant treatment in therapies in which medicaments with oxidative-toxic side effects are used. The invention additionally relates to the production of medicaments suitable for said prophylaxis and/or treatment or adjuvant treatment.
-
公开(公告)号:DE59606160D1
公开(公告)日:2001-01-04
申请号:DE59606160
申请日:1996-03-18
Applicant: SOLVAY PHARM GMBH
Inventor: WALDECK HARALD , HOELTJE DAGMAR , MESSINGER JOSEF , ANTEL JOCHEN , WURL MICHAEL , THORMAEHLEN DIRK
IPC: C07D223/16 , A61K31/33 , A61K31/423 , A61K31/428 , A61K31/55 , A61K31/554 , A61K38/00 , A61K38/05 , A61P7/10 , A61P9/00 , A61P43/00 , C07D267/14 , C07D281/10 , C07K5/078
Abstract: Benzazepin-, benzoxazepin- and benzothiazepin-N-acetic acid derivs. of formula (I) and their salts are new. R = lower alkoxy(lower)alkyl (in which the alkoxy is opt. substd. by lower alkoxy) or phenyl(lower)alkyl, or phenoxy(lower)alkyl (opt. ring substd. by lower alkyl or alkoxy or halo) or naphthyl(lower)alkyl; A = CH2, O or S; R , R = H or halogen; R , R = H or a biolabile ester containing gp.
-
公开(公告)号:DE19906310A1
公开(公告)日:2000-08-17
申请号:DE19906310
申请日:1999-02-16
Applicant: SOLVAY PHARM GMBH
Inventor: WILKINS MARTIN R , THORMAEHLEN DIRK , WALDECK HARALD
IPC: C07D223/16 , A61K31/55 , A61P9/00 , A61P9/12
Abstract: 3-(1-(2-Aralkyl-2-carboxyethyl)-1-cyclopentanecarboxamido)-2,3,4,5-tet rahydro-2-oxo-1H-benz(b)azepine-1-acetic acid derivatives (I) are used to prepare pharmaceutical compositions for treating hypertension in large mammals and humans. 3-(1-(2-Aralkyl-2-carboxyethyl)-1-cyclopentanecarboxamido)-2,3,4,5-tet rahydro-2-oxo-1H-benz(b)azepine-1-acetic acid derivatives of formula (I) or their salts are used to prepare pharmaceutical compositions for treating hypertension in large mammals and humans. R = phenyl- or naphthyl-substituted lower alkyl, where phenyl is optionally substituted by lower alkyl, lower alkoxy or halogen; R , R = H or biolabile ester groups.
-
公开(公告)号:BR9804582A
公开(公告)日:2000-05-09
申请号:BR9804582
申请日:1998-11-11
Applicant: SOLVAY PHARM GMBH
Inventor: WALDECK HARALD , MEIL JOERG , THORMAEHLEN DIRK , WURL MICHAEL
IPC: A61K31/675 , A61K31/00 , A61K31/55 , A61K38/00 , A61K38/05 , A61P9/00 , A61P9/04 , A61P9/12 , C07D223/16 , C07F9/38 , C07F9/40 , C07F9/553 , C07K5/06
Abstract: 3-(1-Phosphonomethyl-cyclopentane-1-carbonylamino)-2,3,4,5-tetrahydro- 2-oxo-1H-1-benzazepine-1-acetic acid derivatives (I) are new. Benzazepine derivatives of formula (I) and their salts are new: R1-R3 = H or biolabile ester residue. An Independent claim relates to the preparation of (I).
-
公开(公告)号:PL329635A1
公开(公告)日:1999-05-24
申请号:PL32963598
申请日:1998-11-10
Applicant: SOLVAY PHARM GMBH
Inventor: WALDECK HARALD , MEIL JOERG , THORMAEHLEN DIRK , WURL MICHAEL
IPC: A61K31/675 , A61K31/00 , A61K31/55 , A61K38/00 , A61K38/05 , A61P9/00 , A61P9/04 , A61P9/12 , C07D223/16 , C07F9/38 , C07F9/40 , C07F9/553 , C07K5/06 , A61K33/42
Abstract: 3-(1-Phosphonomethyl-cyclopentane-1-carbonylamino)-2,3,4,5-tetrahydro- 2-oxo-1H-1-benzazepine-1-acetic acid derivatives (I) are new. Benzazepine derivatives of formula (I) and their salts are new: R1-R3 = H or biolabile ester residue. An Independent claim relates to the preparation of (I).
-
-
-
-
-